IPRATROPIUM BROMIDE J Code: J7644
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
Q4 2026 Medicare Payment Limit for J7644, effective October 1, 2026: $0.445 per HCPCS billing unit, up 0.2% from $0.444. From CMS's final file.
Drug & Product Overview
About IPRATROPIUM BROMIDE
Ipratropium Bromide is a medication aligned to the HCPCS J Code: J7644 for billing, pricing, and reimbursement purposes in the United States. This Respiratory medication is administered via the inhalation route and manufactured by multiple companies.
According to CMS Drug Use Information: Ipratropium is used to control and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. For preventing symptoms of lung disease, this medication must be used regularly to be effective. Use your quick-relief inhaler or nebulized solution (such as albuterol, also called salbutamol in some countries) for wheezing or sudden shortness of breath unless otherwise directed by your doctor. Ipratropium does not work as fast as your quick-relief medication, but may sometimes be used together with your quick-relief medication to relieve symptoms of wheezing or sudden shortness of breath if so prescribed by your doctor.
Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.
NDC Code Information
Based on publicly available CMS files. Showing 5 of 23 NDCs — log in for the full crosswalk.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| 00378-7970-52 | Ipratropium Bromide | Mylan Pharmaceuticals Inc. | 13 | 0.5 MG / 2.5 ML |
| 00487-9801-01 | Ipratropium Bromide | Nephron Pharmaceuticals Corporation | 15 | 0.5 MG / 2.5 ML |
| 47335-0706-49 | Ipratropium Bromide | Sun Pharmaceutical Industries, Inc. | 13 | 0.5 MG / 2.5 ML |
| 50090-0668-00 | Ipratropium Bromide | A-S Medication Solutions | 13 | 0.5 MG / 2.5 ML |
| 62135-0830-84 | Ipratropium Bromide | Chartwell RX, LLC | 15 | 0.5 MG / 2.5 ML |
| •••••-••••-•• Log in to view | IPRATROPIUM BROMIDE | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
| •••••-••••-•• Log in to view | IPRATROPIUM BROMIDE | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
| •••••-••••-•• Log in to view | IPRATROPIUM BROMIDE | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
IPRATROPIUM BROMIDE Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →Historical Graphing and Billing Calculator
Log in to calculate billing and reimbursement with live ASP, WAC & AWP pricing.
Login to use the calculator →IPRATROPIUM BROMIDE CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction or for sputum induction for diagnostic purposes. |
CMS does not include Ipratropium Bromide (J7644) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J7644. Wastage billing guide →
IPRATROPIUM BROMIDE Medically Unlikely Edits (MUE)
The most billing units of J7644 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg. The limit is different in the office and the hospital. Use the one for your setting.
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
IPRATROPIUM BROMIDE Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Ipratropium Bromide billing and coding guide?
Are there any available Ipratropium Bromide patient assistance programs?
Where can I find Ipratropium Bromide prescribing information?
Where can I find Ipratropium Bromide side effect information?
Does billing IPRATROPIUM BROMIDE require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to IPRATROPIUM BROMIDE.